標題
返回
確定
Topics
Business
Business
AI & Semiconductor
AI & Semiconductor
Taiwan
Taiwan
China
China
World
World
Editorial
Editorial
Topics
Business
Business
AI & Semiconductor
AI & Semiconductor
Taiwan
Taiwan
China
China
World
World
Editorial
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Home
Innovent Biologics
#
Innovent Biologics
About 2 search results
Sort by Date
Business
PR Newswire
2026 ASCO | Innovent Presents Long-Term Follow-up Results from the PoC Study of IBI363 (TAK-928) (PD-1/IL-2α-bias bispecific fusion protein), Showing Robust Survival Benefits in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer
SAN FRANCISCO and SUZHOU, China
PR Newswire
2026-06-01 08:00
IBI363
TAK-928
Innovent Biologics
PR Newswire
News
Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
SAN FRANCISCO and NEW YORK, and SUZHOU, China
PR Newswire
2026-05-29 07:00
Innovent Biologics
Pfizer
oncology